Home
Home
Company Information
Calender of Events
FAQs
Share Price
Financial Reports
Press Releases
News Alert Service
Sitemap
Home
Company Information
Company Overview
Company Directors
Company History
Statutory Information
Calender of Events
FAQs
Share Price
Financial Reports
Theratase Scheme
BBI Readmission
Annual Report 2006
Interim Report 2006
Annual Report 2005
Interim Report 2005
Annual Report 2004
Interim Report 2004
Annual Report 2003
Interim Report 2003
Annual Report 2002
Interim Report 2002
Annual Report 2001
Interim Report 2001
Annual Report 2000
Interim Report 2000
Annual Report 1999
Interim Report 1999
Press Releases
Offer for Theratase plc
Holdings in Company
Holdings in Company
Result of AGM
AGM Statement
Holdings in Company
Holdings in Company
Warning to shareholders re unsolicited phone calls
Annual Information Update
Doc re Annual Report
Holdings in Company
Investment in Alloksys
TRADING UPDATE – SALES TO KOREA
Statement re: Possible Offer
Preliminary Results for the year ended 30 September 2006
Voting Rights and Capital
AM-Pharma trial results
Holdings in Company
Alloksys Life Sciences initiates Phase II clinical trials
Statement Re Joanne Rooke
Interim results
Notification of Results
Holdings in Company
Holdings in Company
Holdings in Company
SAR 5 - Theratase plc
Holdings in Company
Director/PDMR Shareholding
Holdings in Company
Holdings in Company
Additional Listing
Holdings in Company
Holdings in Company
Director/PDMR Shareholding
Result of AGM
AGM Statement
Resignation of Director and change of Company Secretary
Annual Information Update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Preliminary Results for the Year Ended 30 Sept 05
Notice of Results
Hermes Investment Management
Holding(s) in Company
Holding(s) in Company
Investment in AM-Pharma
Directorate Change
Holding(s) in Company
Hermes Investment Management
Holding(s) in Company
Hermes Investment Management
Notification of Interest
Director Shareholding
Director Shareholding
Director Shareholding
Director Shareholding
Director Shareholding
Interim Results correction
Interim Results for the six months ended 31 March 2005
Share Option Plan
Notification of Results
Additional Listing
Holding(s) in Company
AGM Statement
Additional Listing
Dir. Sharehold & Add. Listing
Preliminary Results for the year ended 30 Sept 2004
Notification of Preliminary Results
New Agreements With ISTA Pharmaceuticals Inc.
Vitrase
EGM Statement
Acquisition of Seravac Biotech (Pty) Ltd
Preliminary Results for the Year Ended 30 Sept 2003
Preliminary Results For the year ended 30 Sept 2003
Subsidiary Signs New 3-Year Supply Agreement Deal
New Drug Application To The FDA
Interim Results For the six months ended 31 March 2003
News Alert Service
© Copyright Theratase plc. All rights reserved. Site designed by
Rede Digital
Home
|
Company Information
|
Calender of Events
|
FAQs
Share Price
|
Financial Reports
|
Press Releases
|
News Alert Service
